Anaphore acquires Chinese business and picks up final Series A tranche
This article was originally published in Scrip
Executive Summary
Anaphore Inc, a small private San Diego biotechnology company has acquired a startup in China to build on the strengths of both very early-stage firms while simultaneously receiving the last $15 million of its Series A venture capital financing.